|
Delayed
NSE India S.E.
11:52:35 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 509.40 INR | -2.26% |
|
-4.10% | +15.28% |
| Market Cap | 36.62B 387M 345M 321M 292M 549M 559M 3.85B 1.51B 19.11B 1.45B 1.42B 61.14B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 38.72B 409M 365M 339M 309M 580M 591M 4.07B 1.59B 20.2B 1.53B 1.5B 64.65B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | -2.27% | ||
| 1 week | -4.10% | ||
| Current month | -6.63% | ||
| 1 month | -2.84% | ||
| 3 months | -15.79% | ||
| 6 months | +46.85% | ||
| Current year | +15.28% |
| 1 week | 505.05 |  | 540.95 |
| 1 month | 505.05 | | 608 |
| Current year | 278.2 | | 687.2 |
| 1 year | 278.2 | | 687.2 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.26% | -4.10% | - | - | 387M | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,116B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 610B | |
| -0.03% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 358B | |
| -0.59% | +5.25% | +32.00% | +49.36% | 366B | |
| -1.05% | +4.45% | +19.23% | +42.66% | 288B | |
| -1.72% | +3.98% | -0.62% | +13.71% | 261B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 235B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 195B | |
| Average | +0.05% | +5.27% | +34.60% | +62.14% | 436.64B | |
| Weighted average by Cap. | +0.82% | +4.93% | +38.22% | +71.64% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 223M 199M 185M 168M 316M 322M 2.22B 869M 11.01B 836M 819M 35.24B | 22.02B 232M 208M 193M 175M 330M 336M 2.32B 906M 11.49B 872M 854M 36.76B |
| Net income | 1.38B 14.52M 12.96M 12.05M 10.96M 20.61M 20.98M 145M 56.61M 718M 54.49M 53.33M 2.3B | 2.53B 26.69M 23.83M 22.15M 20.14M 37.9M 38.58M 266M 104M 1.32B 100M 98.06M 4.22B |
| Net Debt | 3.7B 39.08M 34.89M 32.42M 29.49M 55.49M 56.49M 389M 152M 1.93B 147M 144M 6.18B | 2.11B 22.24M 19.85M 18.45M 16.78M 31.58M 32.15M 222M 86.72M 1.1B 83.47M 81.7M 3.52B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | ₹509.40 | -2.26% | 27,448 |
| 15/10/26 | ₹521.20 | +0.29% | 20,421 |
| 14/10/26 | ₹519.70 | -1.26% | 26,429 |
| 13/10/26 | ₹526.35 | -0.67% | 27,657 |
| 12/10/26 | ₹529.90 | -0.23% | 23,650 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
